Insider · CIK 0001503559
Flagship Ventures Fund IV, L.P.
Files at: KLDO, MRNA, RUBY, EVLO, SYRS, SESN, EDIT, MCRB. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2017 JForm 4 → | Aug 21, 4:19 pm EDT | Syros Pharmaceuticals, Inc.SYRS | 1,656,512 | — | — | 0 | — | plan? |
| Sep 22, 2016 SForm 4 → | Sep 26, 4:03 pm EDT | Eleven Biotherapeutics, Inc.EBIO | 443,422 | $3.16 | $1,403,298 | 106,787 | −80.6% | plan? |
| Sep 19, 2016 SForm 4 → | Sep 21, 5:37 pm EDT | Eleven Biotherapeutics, Inc.EBIO | 386,340 | $3.69 | $1,425,097 | 195,451 | −66.4% | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 4:15 pm EDT | Eleven Biotherapeutics, Inc.EBIO | 46,692 | $4.18 | $195,119 | 272,677 | −14.6% | plan? |
| Sep 6, 2016 SForm 4 → | Sep 8, 6:53 pm EDT | Eleven Biotherapeutics, Inc.EBIO | 129,497 | $4.54 | $588,324 | 282,015 | −31.5% | plan? |
| Aug 11, 2016 JForm 4 → | Aug 15, 5:22 pm EDT | Editas Medicine, Inc.EDIT | 1,550,271 | — | — | 0 | — | plan? |
| Jul 6, 2016 PForm 4 → | Jul 7, 6:04 am EDT | Syros Pharmaceuticals, Inc.SYRS | 400,000 | $12.50 | $5,000,000 | 918,664 | +77.1% | plan? |
| Jul 6, 2016 CForm 4 → | Jul 7, 6:04 am EDT | Syros Pharmaceuticals, Inc.SYRS | 4,193,324 | — | — | 838,664 | — | plan? |
| Feb 8, 2016 CForm 4 → | Feb 9, 6:08 pm EST | Editas Medicine, Inc.EDIT | 4,955,316 | — | — | 991,060 | — | plan? |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2016 CForm 4 → | Jul 7, 6:04 am EDT | Syros Pharmaceuticals, Inc.SYRS | 15,724,976 | — | — | 0 | — | |
| Feb 8, 2016 CForm 4 → | Feb 9, 6:08 pm EST | Editas Medicine, Inc.EDIT | 12,883,842 | — | — | 0 | — |